Safety and Efficacy of Erythropoietin in Traumatic Brain Injury Patients: A Pilot Randomized Trial

Table 2

Daily NSE and S-100B levels by study group.

	NSE		S-100B
Day	EPO	Placebo	EPO	Placebo
Admission	34.4 (20.9)	24.9 (21.0)	0.087 (0.04)	0.094 (0.05)
1	20.0 (9.9)	16.4 (6.4)	0.035 (0.01)	0.041 (0.03)
2	20.3 (16.4)	9.4 (4.0)	0.025 (0.009)	0.031 (0.02)
3	9.5 (10.5)	7.8 (7.6)	0.017 (0.006)	0.016 (0.004)
4	8.9 (7.3)	11.2 (13.4)	0.016 (0.005)	0.016 (0.004)
5	10.8 (9.2)	4.1 (1.8)	0.016 (0.005)	0.016 (0.003)